2014年3月21日，国(guo)家中医药管理局科(ke)技司(si)(si)副司(si)(si)长(zhang)、中国(guo)中医科(ke)学院(yuan)副院(yuan)长(zhang)、全(quan)国(guo)中药资源普查试点工作专家组组长(zhang)黄璐(lu)琦等(deng)人一行，在淮北市科(ke)技局有关领导陪同下，到华润金蟾调研企业中药发展情况。

黄璐(lu)琦副(fu)司(si)长一行深入华(hua)(hua)(hua)润(run)金(jin)蟾(chan)(chan)蟾(chan)(chan)蜍(chu)养(yang)(yang)(yang)殖(zhi)基(ji)地(di)(di)及(ji)中(zhong)(zhong)药材(cai)(cai)(cai)种(zhong)(zhong)植(zhi)(zhi)基(ji)地(di)(di)，察看了蟾(chan)(chan)蜍(chu)养(yang)(yang)(yang)殖(zhi)及(ji)中(zhong)(zhong)药材(cai)(cai)(cai)的(de)长势(shi)情(qing)况，仔细听取(qu)了公(gong)司(si)负责人对(dui)华(hua)(hua)(hua)润(run)金(jin)蟾(chan)(chan)中(zhong)(zhong)药材(cai)(cai)(cai)种(zhong)(zhong)养(yang)(yang)(yang)殖(zhi)情(qing)况的(de)介绍。黄璐(lu)琦在调研中(zhong)(zhong)对(dui)华(hua)(hua)(hua)润(run)金(jin)蟾(chan)(chan)的(de)蟾(chan)(chan)蜍(chu)养(yang)(yang)(yang)殖(zhi)及(ji)中(zhong)(zhong)药材(cai)(cai)(cai)种(zhong)(zhong)植(zhi)(zhi)给予充(chong)分肯定，并(bing)(bing)对(dui)中(zhong)(zhong)药材(cai)(cai)(cai)种(zhong)(zhong)养(yang)(yang)(yang)植(zhi)(zhi)提(ti)出了宝贵的(de)意见及(ji)建(jian)议(yi)。他强调，华(hua)(hua)(hua)润(run)金(jin)蟾(chan)(chan)作为华(hua)(hua)(hua)润(run)三九的(de)配方颗粒(li)(li)生产(chan)基(ji)地(di)(di)，从产(chan)品质量及(ji)成(cheng)本控制(zhi)等方面出发(fa)，华(hua)(hua)(hua)润(run)金(jin)蟾(chan)(chan)应积极筹建(jian)中(zhong)(zhong)药材(cai)(cai)(cai)规范(fan)化生产(chan)基(ji)地(di)(di)，促进中(zhong)(zhong)药材(cai)(cai)(cai)规范(fan)化种(zhong)(zhong)植(zhi)(zhi)，大力发(fa)展配方颗粒(li)(li)大品种(zhong)(zhong)的(de)药材(cai)(cai)(cai)GAP基(ji)地(di)(di)建(jian)设，并(bing)(bing)就目前(qian)华(hua)(hua)(hua)润(run)金(jin)蟾(chan)(chan)在蟾(chan)(chan)蜍(chu)养(yang)(yang)(yang)殖(zhi)过程中(zhong)(zhong)出现的(de)技术瓶颈与华(hua)(hua)(hua)润(run)金(jin)蟾(chan)(chan)的(de)技术人员进行了深入的(de)探讨(tao)。